Bellerophon Therapeutics Inc buy marge
Start price
12.04.17
/
50%
€16.37
Target price
23.01.20
€67.65
Performance (%)
-68.11%
End price
23.01.20
€5.22
Summary
This prediction ended on 23.01.20 with a price of €5.22. Massive losses of -68.11% were the result for the BUY prediction by marge. marge has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Bellerophon Therapeutics Inc | - | - | - | - |
iShares Core DAX® | 0.160% | -1.640% | 12.016% | 15.557% |
iShares Nasdaq 100 | -3.020% | -4.715% | 37.102% | 42.685% |
iShares Nikkei 225® | -2.519% | -7.621% | 18.066% | 2.904% |
iShares S&P 500 | -1.377% | -2.809% | 26.536% | 41.689% |
Comments by marge for this prediction
In the thread Bellerophon Therapeutics Inc diskutieren
marge stimmt der Buy-Einschätzung von datca zu
marge stimmt am 12.04.2017 der Buy-Einschätzung von datca mit dem Kursziel 5$ zu.
Überschrift: Bellerophon, erfolgreich tätig im Markt der Pulmonary Arterial Hypertension
Buy beendet
Buy beendet